Pharmaceuticals, Biotechnology and Life Sciences
– FCR001 established durable immune tolerance in 70% of patients – Results support initiation of Phase 3 registration study later…
DUBLIN–(BUSINESS WIRE)–The “Phenylketonuria (PKU) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers comprehensive…
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its board of directors has declared a regular quarterly…
Ipsen’s Rare Diseases portfolio significantly enhanced with late-stage drug candidate, palovarotene, for the treatment of rare bone disorders in adult…
PANGYO, South Korea & MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–SK Biopharmaceuticals, a pharmaceutical company focused on disorders of central nervous system and…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative…
IRVINE, Calif.–(BUSINESS WIRE)–The Cystinosis Research Foundation (CRF), the largest provider of grants for cystinosis research in the world, raised a…
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), will announce its first-quarter 2019 financial results…
Conference Call and Webcast Scheduled for 1:30 p.m. PDT SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…
– Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc.…